Non-pharmaceutical interventions to optimize cancer immunotherapy

References

• Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–15. doi:10.1056/NEJMoa1003466.
   PubMed Web of Science ®Google Scholar
• Boesch M, Baty F, Rothschild SI, Tamm M, Joerger M, Fruh M, Brutsche MH. Tumour neoantigen mimicry by microbial species in cancer immunotherapy. Br J Cancer. 2021;125(3): 313–323. doi:10.1038/s41416-021-01365-2.
   PubMed Web of Science ®Google Scholar
• Boesch M, Horvath L, Baty F, Pircher A, Wolf D, Spahn S, Straussman R, Tilg H, Brutsche MH. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects. J Immunother Cancer. 2022;10(11):e005401. doi:10.1136/jitc-2022-005401.
   PubMed Web of Science ®Google Scholar
• Boesch M, Baty F, Kowatsch T, Wolf D, Fruh M, Brutsche MH. Call for a holistic framework for cancer immunotherapy. Cancer. 2022;128(21):3772–3774. doi:10.1002/cncr.34467.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Sci. 2011;334(6052):105–108. doi:10.1126/science.1208344.
   PubMed Web of Science ®Google Scholar
• Muegge BD, Kuczynski J, Knights D, Clemente JC, Gonzalez A, Fontana L, Henrissat B, Knight R, Gordon JI. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Sci. 2011;332(6032):970–974.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2022;21(4):236–247. doi:10.1038/s41579-022-00805-x.
   PubMed Web of Science ®Google Scholar
• Zeng X, Xing X, Gupta M, Keber FC, Lopez JG, Lee YJ, Roichman A, Wang L, Neinast MD, Donia MS, et al. Gut bacterial nutrient preferences quantified in vivo. Cell. 2022;185(18):3441–56 e19.
   PubMed Web of Science ®Google Scholar
• Zhang C, Derrien M, Levenez F, Brazeilles R, Ballal SA, Kim J, Degivry M-C, Quéré G, Garault P, van Hylckama Vlieg JET, et al. Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes. ISME J. 2016;10(9):2235–2245. doi:10.1038/ismej.2016.13.
   PubMed Web of Science ®Google Scholar
• Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, Topf M, Gonzalez CG, Van Treuren W, Han S, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137–53 e14.
   PubMed Web of Science ®Google Scholar
• Derosa L, Hellmann MD, Spaziano M, Halpenny D, Fidelle M, Rizvi H, Long N, Plodkowski AJ, Arbour KC, Chaft JE, et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol. 2018;29(6):1437–1444. doi:10.1093/annonc/mdy103.
   PubMed Web of Science ®Google Scholar
• Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Sci. 2021;371(6529):602–609. doi:10.1126/science.abb5920.
   PubMed Web of Science ®Google Scholar
• Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CPM, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Sci. 2015;350(6264):1079–1084. doi:10.1126/science.aad1329.
   PubMed Web of Science ®Google Scholar
• Boesch M, Baty F, Albrich WC, Flatz L, Rodriguez R, Rothschild SI, et al. Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology. 2021;10(1):1988403.
   PubMed Web of Science ®Google Scholar
• Malczewski AB, Navarro S, Coward JI, Ketheesan N. Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy. J Immunother Cancer. 2020;8(2):e001383. doi:10.1136/jitc-2020-001383.
   PubMed Web of Science ®Google Scholar
• Matson V, Gajewski TF. Dietary modulation of the gut microbiome as an immunoregulatory intervention. Cancer Cell. 2022;40(3):246–248. doi:10.1016/j.ccell.2022.02.014.
   PubMed Web of Science ®Google Scholar
• Levesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 2019;8(7):1591878. doi:10.1080/2162402X.2019.1591878.
   PubMed Web of Science ®Google Scholar
• Malczewski AB, Ketheesan N, Coward JIG, Navarro S. Enhancing checkpoint inhibitor therapy in solid tissue cancers: the role of diet, the microbiome & microbiome-derived metabolites. Front Immunol. 2021;12:624434. doi:10.3389/fimmu.2021.624434.
   PubMed Web of Science ®Google Scholar
• Rescigno M. Training the microbiota to increase immune checkpoint blockade and to reduce toxicity. Eur J Immunol. 2023;e2250183. doi:10.1002/eji.202250183.
   PubMed Web of Science ®Google Scholar
• Ringel AE, Drijvers JM, Baker GJ, Catozzi A, Garcia-Canaveras JC, Gassaway BM, Miller BC, Juneja VR, Nguyen TH, Joshi S, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183(7):1848–66 e26.
   PubMed Web of Science ®Google Scholar
• Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014;514(7523):508–512.
   PubMed Web of Science ®Google Scholar
• Kuehm LM, Khojandi N, Piening A, Klevorn LE, Geraud SC, McLaughlin NR, Griffett K, Burris TP, Pyles KD, Nelson AM, et al. Fructose promotes cytoprotection in melanoma tumors and resistance to immunotherapy. Cancer Immunol Res. 2021;9(2):227–238.
   PubMed Web of Science ®Google Scholar
• Vernieri C, Fuca G, Ligorio F, Huber V, Vingiani A, Iannelli F, Raimondi A, Rinchai D, Frigè G, Belfiore A, et al. Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Discov. 2022;12(1):90–107. doi:10.1158/2159-8290.CD-21-0030.
   PubMed Web of Science ®Google Scholar
• Ligorio F, Fuca G, Provenzano L, Lobefaro R, Zanenga L, Vingiani A, Belfiore A, Lorenzoni A, Alessi A, Pruneri G, et al. Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: a sub-analysis of the NCT03340935 trial. Eur J Cancer. 2022;172:300–310. doi:10.1016/j.ejca.2022.05.046.
   PubMed Web of Science ®Google Scholar
• Turbitt WJ, Demark-Wahnefried W, Peterson CM, Norian LA. Targeting glucose metabolism to enhance immunotherapy: emerging evidence on intermittent fasting and calorie restriction mimetics. Front Immunol. 2019;10:1402. doi:10.3389/fimmu.2019.01402.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–762. doi:10.1038/nrc3829.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Lopez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20(4): 250–264. doi:10.1038/s41571-023-00734-5.
   PubMed Web of Science ®Google Scholar
• Yoo SK, Chowell D, Valero C, Morris LGT, Chan TA. Outcomes among patients with or without obesity and with cancer following treatment with immune checkpoint blockade. JAMA Netw Open. 2022;5(2):e220448. doi:10.1001/jamanetworkopen.2022.0448.
   PubMed Web of Science ®Google Scholar
• Buque A, Galluzzi L, Kroemer G. Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy. Mol Cell Oncol. 2021;8:1868266.
   PubMed Web of Science ®Google Scholar
• Ferrere G, Tidjani Alou M, Liu P, Goubet AG, Fidelle M, Kepp O, Durand S, Iebba V, Fluckiger A, Daillère R, et al. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade. JCI Insight. 2021;6(2). doi:10.1172/jci.insight.145207.
   PubMed Web of Science ®Google Scholar
• Dai X, Bu X, Gao Y, Guo J, Hu J, Jiang C, Zhang Z, Xu K, Duan J, He S, et al. Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade. Mol Cell. 2021;81(11):2317–31 e6.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Derosa L, Kroemer G. Modulation of cancer immunotherapy by dietary fibers and over-the-counter probiotics. Cell Metab. 2022;34(3):350–352. doi:10.1016/j.cmet.2022.02.004.
   PubMed Web of Science ®Google Scholar
• Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Sci. 2021;374(6575):1632–1640. doi:10.1126/science.aaz7015.
   PubMed Web of Science ®Google Scholar
• Simpson RC, Shanahan ER, Batten M, Reijers ILM, Read M, Silva IP, Versluis JM, Ribeiro R, Angelatos AS, Tan J, et al. Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome. Nat Med. 2022;28(11):2344–2352. doi:10.1038/s41591-022-01965-2.
   PubMed Web of Science ®Google Scholar
• Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lopès A, Johnson SB, Schwarz B, Bohrnsen E, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184(21):5338–56 e21.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Sci. 2018;359(6371):97–103.
   PubMed Web of Science ®Google Scholar
• Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y, Zheng H, Yao C, Wang Y, Lu S. The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC. J Thorac Oncol. 2019;14(8):1378–1389.
   PubMed Web of Science ®Google Scholar
• McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D, Pescatello LS, Bloodgood B, Tennant B, Vaux-Bjerke A, et al. Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc. 2019;51(6):1252–1261.
   PubMed Web of Science ®Google Scholar
• Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de Gonzalez A, Hartge P, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176(6):816–825. doi:10.1001/jamainternmed.2016.1548.
   PubMed Web of Science ®Google Scholar
• Renman D, Gylling B, Vidman L, Boden S, Strigard K, Palmqvist R, Harlid S, Gunnarsson U, van Guelpen B. Density of CD3(+) and CD8(+) cells in the microenvironment of colorectal cancer according to prediagnostic physical activity. Cancer Epidemiol Biomarkers Prev. 2021;30(12):2317–2326.
   PubMed Web of Science ®Google Scholar
• Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–571. doi:10.1038/nature13954.
   PubMed Web of Science ®Google Scholar
• Kurz E, Hirsch CA, Dalton T, Shadaloey SA, Khodadadi-Jamayran A, Miller G, Pareek S, Rajaei H, Mohindroo C, Baydogan S, et al. Exercise-induced engagement of the IL-15/IL-15Ralpha axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell. 2022;40(7): 720–737.e5. doi:10.1016/j.ccell.2022.05.006.
   PubMed Web of Science ®Google Scholar
• Conlon K, Watson DC, Waldmann TA, Valentin A, Bergamaschi C, Felber BK, Peer CJ, Figg WD, Potter EL, Roederer M, et al. Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors. J Immunother Cancer. 2021;9(11):e003388. doi:10.1136/jitc-2021-003388.
   PubMed Web of Science ®Google Scholar
• Martin-Ruiz A, Fiuza-Luces C, Rincon-Castanedo C, Fernandez-Moreno D, Galvez BG, Martinez-Martinez E, Martín-Acosta P, Coronado MJ, Franco-Luzón L, González-Murillo Á, et al. Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. Exerc Immunol Rev. 2020;26:100–115.
   PubMed Web of Science ®Google Scholar
• Pedersen KS, Gatto F, Zerahn B, Nielsen J, Pedersen BK, Hojman P, Gehl J. Exercise-mediated lowering of glutamine availability suppresses tumor growth and attenuates muscle wasting. iScience. 2020;23(4):100978.
   PubMed Web of Science ®Google Scholar
• Bay ML, Unterrainer N, Stagaard R, Pedersen KS, Schauer T, Staffeldt MM, Christensen JF, Hojman P, Pedersen BK, Gehl J. Voluntary wheel running can lead to modulation of immune checkpoint molecule expression. Acta Oncol. 2020;59(12):1447–1454.
   PubMed Web of Science ®Google Scholar
• Gerritsen JK, Vincent AJ. Exercise improves quality of life in patients with cancer: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2016;50(13):796–803. doi:10.1136/bjsports-2015-094787.
   PubMed Web of Science ®Google Scholar
• Groen WG, Naaktgeboren WR, van Harten WH, van Vulpen JK, Kool N, Sonke GS, van der Wall E, Velthuis MJ, Aaronson NK, May AM, et al. Physical Fitness and Chemotherapy Tolerance in patients with early-stage breast cancer. Med Sci Sports Exerc. 2022;54(4):537–542.
   PubMed Web of Science ®Google Scholar
• Hyatt A, Gough K, Murnane A, Au-Yeung G, Dawson T, Pearson E, Dhillon H, Sandhu S, Williams N, Paton E, et al. I-move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol. BMJ Open. 2020;10(2):e036059. doi:10.1136/bmjopen-2019-036059.
   PubMed Web of Science ®Google Scholar
• Matzka M, Mayer H, Kock-Hodi S, Moses-Passini C, Dubey C, Jahn P, Schneeweiss S, Eicher M. Relationship between resilience, psychological distress and physical activity in cancer patients: a cross-sectional observation study. PloS One. 2016;11(4):e0154496.
   PubMed Web of Science ®Google Scholar
• Song H, Fall K, Fang F, Erlendsdottir H, Lu D, Mataix-Cols D, Fernández de la Cruz L, D’Onofrio BM, Lichtenstein P, Gottfreðsson M, et al. Stress related disorders and subsequent risk of life threatening infections: population based sibling controlled cohort study. BMJ. 2019;367:l5784. doi:10.1136/bmj.l5784.
   PubMedGoogle Scholar
• Glaser R, Kiecolt-Glaser JK, Bonneau RH, Malarkey W, Kennedy S, Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom Med. 1992;54(1):22–29. doi:10.1097/00006842-199201000-00005.
   PubMed Web of Science ®Google Scholar
• Madison AA, Shrout MR, Renna ME, Kiecolt-Glaser JK. Psychological and behavioral predictors of vaccine efficacy: considerations for COVID-19. Perspect Psychol Sci. 2021;16(2):191–203. doi:10.1177/1745691621989243.
   PubMedGoogle Scholar
• Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601–630. doi:10.1037/0033-2909.130.4.601.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–727. doi:10.1038/nri1936.
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The three es of cancer immunoediting. Annu Rev Immunol. 2004;22(1):329–360. doi:10.1146/annurev.immunol.22.012703.104803.
   PubMed Web of Science ®Google Scholar
• Chen Y, Qian Y, Huang W, Zhang Y, Wu M, Cheng Y, Yang N, Liu Y. Chronic stress promotes tumor immune evasion via the suppression of MHC-I expression and the upregulation of PD-L1. Am J Cancer Res. 2022;12(11):5286–5299.
   PubMed Web of Science ®Google Scholar
• Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, Li X, Li Y, Xiong W, Li G, et al. Chronic stress promotes cancer development. Front Oncol. 2020;10:1492. doi:10.3389/fonc.2020.01492.
   PubMed Web of Science ®Google Scholar
• Andersen BL, McElroy JP, Carbone DP, Presley CJ, Smith RM, Shields PG, Brock GN. Psychological symptom trajectories and non-small cell lung cancer survival: a joint model analysis. Psychosom Med. 2022;84(2):215–223.
   PubMed Web of Science ®Google Scholar
• Spiegel D. Mind matters in cancer survival. Psychooncology. 2012;21:588–593.
   PubMed Web of Science ®Google Scholar
• Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T, Lin C, Nefedova Y, Kossenkov A, Liu Q, Sreedhar S, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci Transl Med. 2020;12(572). doi:10.1126/scitranslmed.abb5817.
   PubMed Web of Science ®Google Scholar
• Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29(4):413–420. doi:10.1200/JCO.2010.28.4455.
   PubMed Web of Science ®Google Scholar
• Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25(9):1428–1441.
   PubMed Web of Science ®Google Scholar
• Deng Y, Xia X, Zhao Y, Zhao Z, Martinez C, Yin W, Yao J, Hang Q, Wu W, Zhang J, et al. Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Nat Commun. 2021;12(1):7041. doi:10.1038/s41467-021-27349-7.
   PubMed Web of Science ®Google Scholar
• Qiao G, Chen M, Mohammadpour H, MacDonald CR, Bucsek MJ, Hylander BL, Barbi JJ, Repasky EA. Chronic adrenergic stress contributes to metabolic Dysfunction and an Exhausted Phenotype in T cells in the tumor microenvironment. Cancer Immunol Res. 2021;9(6):651–664.
   PubMed Web of Science ®Google Scholar
• Rijo-Ferreira F, Takahashi JS. Genomics of circadian rhythms in health and disease. Genome Med. 2019;11(1):82. doi:10.1186/s13073-019-0704-0.
   PubMed Web of Science ®Google Scholar
• Boesch M, Zeimet AG, Reimer D, Schmidt S, Gastl G, Parson W, Spoeck F, Hatina J, Wolf D, Sopper S, et al. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget. 2014;5(16):7027–7039. doi:10.18632/oncotarget.2053.
   PubMedGoogle Scholar
• Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG, et al. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response. Int J Cancer. 2018;142(8):1640–1651. doi:10.1002/ijc.31186.
   PubMed Web of Science ®Google Scholar
• Boesch M, Onder L, Cheng HW, Novkovic M, Morbe U, Sopper S, Gastl G, Jochum W, Ruhstaller T, Knauer M, et al. Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. Oncoimmunology. 2018;7(4):e1414129. doi:10.1080/2162402X.2017.1414129.
   PubMed Web of Science ®Google Scholar
• Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, Strittmatter K, Krol I, Seifert B, Heinzelmann-Schwarz V, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. 2022;607(7917):156–162. doi:10.1038/s41586-022-04875-y.
   PubMed Web of Science ®Google Scholar
• Hadadi E, Taylor W, Li XM, Aslan Y, Villote M, Riviere J, Duvallet G, Auriau C, Dulong S, Raymond-Letron I, et al. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat Commun. 2020;11(1):3193. doi:10.1038/s41467-020-16890-6.
   PubMed Web of Science ®Google Scholar
• Kelly RM, Healy U, Sreenan S, McDermott JH, Coogan AN. Clocks in the clinic: circadian rhythms in health and disease. Postgrad Med J. 2018;94:653–658.
   PubMed Web of Science ®Google Scholar
• Lane JM, Qian J, Mignot E, Redline S, Scheer F, Saxena R. Genetics of circadian rhythms and sleep in human health and disease. Nat Rev Genet. 2023;24(1):4–20. doi:10.1038/s41576-022-00519-z.
   PubMedGoogle Scholar
• Dong D, Yang D, Lin L, Wang S, Wu B. Circadian rhythm in pharmacokinetics and its relevance to chronotherapy. Biochem Pharmacol. 2020;178:114045. doi:10.1016/j.bcp.2020.114045.
   PubMed Web of Science ®Google Scholar
• Wang C, Lutes LK, Barnoud C, Scheiermann C. The circadian immune system. Sci Immunol. 2022;7:eabm2465.
   PubMed Web of Science ®Google Scholar
• Druzd D, Matveeva O, Ince L, Harrison U, He W, Schmal C, Herzel H, Tsang AH, Kawakami N, Leliavski A, et al. Lymphocyte circadian clocks control Lymph Node Trafficking and adaptive immune responses. Immunity. 2017;46(1):120–132. doi:10.1016/j.immuni.2016.12.011.
   PubMed Web of Science ®Google Scholar
• Ince LM, Barnoud C, Lutes LK, Pick R, Wang C, Sinturel F, Chen C-S, de Juan A, Weber J, Holtkamp SJ, et al. Influence of circadian clocks on adaptive immunity and vaccination responses. Nat Commun. 2023;14(1):476. doi:10.1038/s41467-023-35979-2.
   PubMed Web of Science ®Google Scholar
• de Bree LCJ, Mourits VP, Koeken VA, Moorlag SJ, Janssen R, Folkman L, Barreca D, Krausgruber T, Fife-Gernedl V, Novakovic B, et al. Circadian rhythm influences induction of trained immunity by BCG vaccination. J Clin Invest. 2020;130(10):5603–5617.
   PubMed Web of Science ®Google Scholar
• Otasowie CO, Tanner R, Ray DW, Austyn JM, BJ C. Chronovaccination: harnessing circadian rhythms to optimize immunisation strategies. Front Immunol. 2022;13:977525.
   PubMed Web of Science ®Google Scholar
• Long JE, Drayson MT, Taylor AE, Toellner KM, Lord JM, Phillips AC. Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial. Vaccine. 2016;34(24):2679–2685. doi:10.1016/j.vaccine.2016.04.032.
   PubMed Web of Science ®Google Scholar
• Long JE, Drayson MT, Taylor AE, Toellner KM, Lord JM, Phillips AC. Corrigendum to ‘morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial. [Vaccine 34 (2016). 2016;34(40):2679–2685]. Vaccine 4842.
   Google Scholar
• Zhang H, Liu Y, Liu D, Zeng Q, Li L, Zhou Q, Li M, Mei J, Yang N, Mo S, et al. Time of day influences immune response to an inactivated vaccine against SARS-CoV-2. Cell Res. 2021;31(11):1215–1217. doi:10.1038/s41422-021-00541-6.
   PubMed Web of Science ®Google Scholar
• Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, Zhong J, Yushak ML, Harvey RD, Paulos CM, et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 2021;22(12):1777–1786. doi:10.1016/S1470-2045(21)00546-5.
   PubMedGoogle Scholar
• Karaboue A, Collon T, Pavese I, Bodiguel V, Cucherousset J, Zakine E, Innominato PF, Bouchahda M, Adam R, Lévi F, et al. Time-dependent efficacy of checkpoint inhibitor nivolumab: results from a Pilot study in patients with metastatic non-small-cell lung cancer. Cancers Basel. 2022;14(4):896. doi:10.3390/cancers14040896.
   PubMed Web of Science ®Google Scholar
• Tsuruta A, Shiiba Y, Matsunaga N, Fujimoto M, Yoshida Y, Koyanagi S, Ohdo S. Diurnal expression of PD-1 on tumor-associated Macrophages Underlies the Dosing time-dependent antitumor effects of the PD-1/PD-L1 inhibitor BMS-1 in B16/BL6 melanoma-bearing mice. Mol Cancer Res. 2022;20(6):972–982.
   PubMed Web of Science ®Google Scholar
• Berner F, Bomze D, Diem S, Ali OH, Fassler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, et al. Association of checkpoint inhibitor-induced toxic effects with shared cancer and tissue antigens in non-small cell lung cancer. JAMA Oncol. 2019;5(7): 1043–1047. doi:10.1001/jamaoncol.2019.0402.
   PubMed Web of Science ®Google Scholar
• Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019;7:306.
   PubMed Web of Science ®Google Scholar
• Rogado J, Sanchez-Torres JM, Romero-Laorden N, Ballesteros AI, Pacheco-Barcia V, Ramos-Levi A, Arranz R, Lorenzo A, Gullón P, Donnay O, et al. Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients. Eur J Cancer. 2019;109:21–27.
   PubMed Web of Science ®Google Scholar
• Eggermont AMM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Khattak A, Carlino MS, et al. Association between immune-related adverse events and recurrence-free survival among patients with stage III melanoma randomized to receive pembrolizumab or placebo: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2020;6(4):519–527. doi:10.1001/jamaoncol.2019.5570.
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Sci. 2018;359(6371):91–97.
   PubMed Web of Science ®Google Scholar
• Schett A, Rothschild SI, Curioni-Fontecedro A, Krahenbuhl S, Fruh M, Schmid S, Driessen C, Joerger M. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors: antibiotics immune checkpoint inhibitors in advanced NSCLC. Cancer Chemother Pharmacol. 2020;85(1):121–131.
   PubMed Web of Science ®Google Scholar
• Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, Blair JMA. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21(5):280–295.
   PubMed Web of Science ®Google Scholar
• Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, et al. Discontinuing beta-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021;397(10280):1195–1203.
   PubMed Web of Science ®Google Scholar
• Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Phiri M, Schmicker R, Hwang J, Ndamala CB, Phiri A, Lufesi N, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children. N Engl J Med. 2020;383(1):13–23. doi:10.1056/NEJMoa1912400.
   PubMed Web of Science ®Google Scholar
• Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, Berdelou A, Varga A, Bahleda R, Hollebecque A, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016;54:139–148. doi:10.1016/j.ejca.2015.11.016.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li X, Huang X, Li J, Ma H, Zeng R. Impact of corticosteroid use on outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. J Clin Pharm Ther. 2021;46:927–935.
   PubMed Web of Science ®Google Scholar
• Li J, Yang K, Zhao L, Bai C, Sun Z. Impact of corticosteroids use on efficacy of immune checkpoint inhibitors in cancer patients: a meta-analysis. J Clin Oncol. 2020;38:e15234–e.
   Google Scholar
• Jessurun CAC, Hulsbergen AFC, de Wit AE, Tewarie IA, Snijders TJ, Verhoeff JJC, Phillips JG, Reardon DA, Mekary RA, Broekman MLD. The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis. Neuro Oncol. 2021;23(8):1261–1272.
   PubMed Web of Science ®Google Scholar
• Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, et al. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022;10(9):e005646. doi:10.1136/jitc-2022-005646.
   PubMed Web of Science ®Google Scholar
• Bessede A, Marabelle A, Guegan JP, Danlos FX, Cousin S, Peyraud F, Chaput N, Spalato M, Roubaud G, Cabart M, et al. Impact of acetaminophen on the efficacy of immunotherapy in cancer patients. Ann Oncol. 2022;33(9):909–915. doi:10.1016/j.annonc.2022.05.010.
   PubMed Web of Science ®Google Scholar
• Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018;378(21):1976–1986. doi:10.1056/NEJMoa1716078.
   PubMed Web of Science ®Google Scholar
• Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386(21):1973–1985. doi:10.1056/NEJMoa2202170.
   PubMed Web of Science ®Google Scholar
• Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, et al. Multivitamins in the prevention of cancer in men: the physicians’ health study II randomized controlled trial. JAMA. 2012;308(18):1871–1880. doi:10.1001/jama.2012.14641.
   PubMed Web of Science ®Google Scholar
• Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol. 2011;173(8):906–914. doi:10.1093/aje/kwq447.
   PubMed Web of Science ®Google Scholar
• Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D’Agostino D, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi:10.1056/NEJMoa1809944.
   PubMed Web of Science ®Google Scholar
• Vaughan-Shaw PG, Buijs LF, Blackmur JP, Theodoratou E, Zgaga L, Din FVN, Farrington SM, Dunlop MG. The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials. Br J Cancer. 2020;123(11):1705–1712.
   PubMed Web of Science ®Google Scholar
• Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev. 2007;33(5):407–418. doi:10.1016/j.ctrv.2007.01.005.
   PubMed Web of Science ®Google Scholar
• Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist. 2015;20(2):210–223. doi:10.1634/theoncologist.2014-0381.
   PubMed Web of Science ®Google Scholar
• van Gorkom GNY, Lookermans EL, Van Elssen C, Bos GMJ. The effect of vitamin C (ascorbic acid) in the treatment of patients with cancer: a systematic review. Nutrients. 2019;11(5).
   PubMed Web of Science ®Google Scholar
• Zaher A, Stephens LM, Miller AM, Hartwig SM, Stolwijk JM, Petronek MS, Zacharias ZR, Wadas TJ, Monga V, Cullen JJ, et al. Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy. Front Immunol. 2022;13:989000. doi:10.3389/fimmu.2022.989000.
   PubMed Web of Science ®Google Scholar
• Magri A, Germano G, Lorenzato A, Lamba S, Chila R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, et al. High-dose vitamin C enhances cancer immunotherapy. Sci Transl Med. 2020;12(532). doi:10.1126/scitranslmed.aay8707.
   PubMed Web of Science ®Google Scholar
• Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr., Levine M, Verma A, Shenoy N. High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proc Natl Acad Sci U S A. 2020;117(3):1666–1677.
   PubMed Web of Science ®Google Scholar
• Li P, Zhu X, Cao G, Wu R, Li K, Yuan W, Chen B, Sun G, Xia X, Zhang H, et al. 1alpha,25(OH)(2)D(3) reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells. J Immunother Cancer. 2022;10(3):e003477. doi:10.1136/jitc-2021-003477.
   PubMed Web of Science ®Google Scholar
• Stucci LS, D’Oronzo S, Tucci M, Macerollo A, Ribero S, Spagnolo F, Marra E, Picasso V, Orgiano L, Marconcini R, et al. Vitamin D in melanoma: controversies and potential role in combination with immune check-point inhibitors. Cancer Treat Rev. 2018;69:21–28. doi:10.1016/j.ctrv.2018.05.016.
   PubMed Web of Science ®Google Scholar
• Yuan X, Duan Y, Xiao Y, Sun K, Qi Y, Zhang Y, Ahmed Z, Moiani D, Yao J, Li H, et al. Vitamin E enhances cancer immunotherapy by reinvigorating dendritic cells via targeting checkpoint SHP1. Cancer Discov. 2022;12(7):1742–1759. doi:10.1158/2159-8290.CD-21-0900.
   PubMed Web of Science ®Google Scholar
• Galus L, Michalak M, Lorenz M, Stoinska-Swiniarek R, Tusien Malecka D, Galus A, Kolenda T, Leporowska E, Mackiewicz J. Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy. Cancer. 2023;129(13): 2047–2055. doi:10.1002/cncr.34718.
   PubMed Web of Science ®Google Scholar
• Xu YP, Lv L, Liu Y, Smith MD, Li WC, Tan XM, Cheng M, Li Z, Bovino M, Aubé J, et al. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Invest. 2019;129(10):4316–4331. doi:10.1172/JCI129317.
   PubMed Web of Science ®Google Scholar
• Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, Rincon-Restrepo M, Franco F, Genolet R, Cheng WC, et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540–1551.
   PubMed Web of Science ®Google Scholar
• Caccialanza R, Cereda E, Agustoni F, Klersy C, Casirati A, Montagna E, Carnio S, Novello S, Milella M, Pilotto S, et al. Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling. BMC Cancer. 2022;22(1):1212. doi:10.1186/s12885-022-10296-x.
   PubMed Web of Science ®Google Scholar
• Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022;40(1):36–52 e9.
   PubMed Web of Science ®Google Scholar
• Kelly MP, Barker M. Why is changing health-related behaviour so difficult? Public Health. 2016;136:109–116. doi:10.1016/j.puhe.2016.03.030.
   PubMed Web of Science ®Google Scholar
• Jacobson NC, Kowatsch T, Marsch LA. Chapter 1 - introduction: a vision for the field of digital therapeutics. In: Jacobson N, Kowatsch T, and Marsch L editors. Digital Therapeutics for Mental Health and addiction. Academic Press; 2023. pp. 1–4. https://www.sciencedirect.com/science/article/abs/pii/B9780323900454000083.
   Google Scholar
• Wang C, Lee C, Shin H. Digital therapeutics from bench to bedside. NPJ Digital Med. 2023;6:38.
   PubMed Web of Science ®Google Scholar
• Fürstenau D, Gersch M, Schreiter S. Digital therapeutics (DTx). Bus Inf Syst Eng. 2023;65(3):349–360. doi:10.1007/s12599-023-00804-z.
   Web of Science ®Google Scholar
• Nahum-Shani I, Smith SN, Spring BJ, Collins LM, Witkiewitz K, Tewari A, Murphy SA. Just-in-time adaptive interventions (JITAIs) in mobile health: key components and design principles for ongoing health behavior support. Ann Behav Med. 2018;52(6):446–462.
   PubMed Web of Science ®Google Scholar
• Hardeman W, Houghton J, Lane K, Jones A, Naughton F. A systematic review of just-in-time adaptive interventions (JITAIs) to promote physical activity. Int J Behav Nutr Phys Act. 2019;16(1):31. doi:10.1186/s12966-019-0792-7.
   PubMed Web of Science ®Google Scholar
• Kowatsch T, Fleisch E. Digital health interventions. In: Gassmann O Ferrandina F, editors Connected business: create value in a networked economy. Cham: Springer International Publishing; 2021. pp. 71–95.
   Google Scholar
• Hurmuz MZM, Jansen-Kosterink SM, Beinema T, Fischer K, Op den Akker H, Hermens HJ. Evaluation of a virtual coaching system eHealth intervention: a mixed methods observational cohort study in the Netherlands. Internet Interv. 2022;27:100501.
   PubMedGoogle Scholar
• Bevilacqua R, Casaccia S, Cortellessa G, Astell A, Lattanzio F, Corsonello A, D'Ascoli P, Paolini S, Di Rosa M, Rossi L, et al. Coaching through technology: a systematic review into efficacy and Effectiveness for the ageing population. Int J Environ Res Public Health. 2020;17(16):5930. doi:10.3390/ijerph17165930.
   PubMed Web of Science ®Google Scholar
• Albers N, Hizli B, Scheltinga BL, Meijer E, Brinkman WP. Setting physical activity goals with a virtual coach: vicarious experiences, personalization and acceptance. J Med Syst. 2023;47(1):15. doi:10.1007/s10916-022-01899-9.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Tam CC, Wu D, Li X, Qiao S. Artificial intelligence-based chatbots for promoting health behavioral changes: systematic review. J Med Internet Res. 2023;25:e40789.
   PubMedGoogle Scholar
• Han R, Todd A, Wardak S, Partridge SR, Raeside R. Feasibility and acceptability of chatbots for nutrition and physical activity health promotion among adolescents: systematic scoping review with adolescent consultation. JMIR Hum Facto. 2023;10:e43227. doi:10.2196/43227.
   PubMedGoogle Scholar
• Martinengo L, Jabir AI, Goh WWT, Lo NYW, Ho MR, Kowatsch T, Atun R, Michie S, Tudor Car L. Conversational agents in health care: scoping review of their behavior change techniques and underpinning theory. J Med Internet Res. 2022;24(10):e39243.
   PubMed Web of Science ®Google Scholar
• Canali S, Schiaffonati V, Aliverti A, Mulvaney S. Challenges and recommendations for wearable devices in digital health: data quality, interoperability, health equity, fairness. PLOS Digit Health. 2022;1(10):e0000104. doi:10.1371/journal.pdig.0000104.
   PubMedGoogle Scholar
• Ferguson T, Olds T, Curtis R, Blake H, Crozier AJ, Dankiw K, Dumuid D, Kasai D, O'Connor E, Virgara R, et al. Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses. Lancet Digit Health. 2022;4(8):e615–e26.
   PubMedGoogle Scholar
• Patel MS, Asch DA, Volpp KG. Wearable devices as facilitators, not drivers, of health behavior change. JAMA. 2015;313(5):459–460. doi:10.1001/jama.2014.14781.
   PubMed Web of Science ®Google Scholar
• Fitzsimmons-Craft EE, Taylor CB, Graham AK, Sadeh-Sharvit S, Balantekin KN, Eichen DM, Monterubio GE, Goel NJ, Flatt RE, Karam AM, et al. Effectiveness of a Digital cognitive behavior therapy-guided self-help intervention for eating disorders in college women: a cluster randomized clinical trial. JAMA Netw Open. 2020;3(8):e2015633.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Mohammadzadeh N, Ayyoubzadeh SM. Evaluation of overweight control applications with cognitive-behavioral therapy approach: a systematic review. Health Sci Rep. 2023;6:e1157.
   PubMedGoogle Scholar
• Hwang H, Kim SM, Netterstrom B, Han DH. The efficacy of a smartphone-based App on stress reduction: randomized controlled trial. J Med Internet Res. 2022;24(2):e28703. doi:10.2196/28703.
   PubMed Web of Science ®Google Scholar
• Schuman-Olivier Z, Trombka M, Lovas DA, Brewer JA, Vago DR, Gawande R, Dunne JP, Lazar SW, Loucks EB, Fulwiler C, et al. Mindfulness and behavior change. Harv Rev Psychiatry. 2020;28(6):371–394. doi:10.1097/HRP.0000000000000277.
   PubMed Web of Science ®Google Scholar
• Roche AI, Kroska EB, Denburg NL. Acceptance- and mindfulness-based interventions for health behavior change: systematic reviews and meta-analyses. J Contextual Behav Sci. 2019;13:74–93.
   PubMed Web of Science ®Google Scholar
• Bailey RR. Goal setting and action planning for health behavior change. Am J Lifestyle Med. 2019;13(6):615–618. doi:10.1177/1559827617729634.
   PubMed Web of Science ®Google Scholar
• Lorig K, Laurent DD, Plant K, Krishnan E, Ritter PL. The components of action planning and their associations with behavior and health outcomes. Chronic Illn. 2014;10(1):50–59. doi:10.1177/1742395313495572.
   PubMedGoogle Scholar
• Kramer JN, Kunzler F, Mishra V, Smith SN, Kotz D, Scholz U, Fleisch E, Kowatsch T. Which components of a smartphone walking app help users to reach personalized step goals? Results from an optimization trial. Ann Behav Med. 2020;54(7):518–528.
   PubMed Web of Science ®Google Scholar
• Tagliabue M, Squatrito V, Presti G. Models of cognition and their applications in behavioral economics: a conceptual framework for nudging derived from behavior analysis and relational frame theory. Front Psychol. 2019;10:2418. doi:10.3389/fpsyg.2019.02418.
   PubMed Web of Science ®Google Scholar
• Van Dessel P, Boddez Y, Hughes S. Nudging societally relevant behavior by promoting cognitive inferences. Sci Rep. 2022;12(1):9201. doi:10.1038/s41598-022-12964-1.
   PubMed Web of Science ®Google Scholar
• Edwards EA, Lumsden J, Rivas C, Steed L, Edwards LA, Thiyagarajan A, Sohanpal R, Caton H, Griffiths CJ, Munafò MR, et al. Gamification for health promotion: systematic review of behaviour change techniques in smartphone apps. BMJ Open. 2016;6(10):e012447. doi:10.1136/bmjopen-2016-012447.
   PubMed Web of Science ®Google Scholar
• Lukic YX, Teepe GW, Fleisch E, Kowatsch T. Breathing as an input modality in a gameful breathing training app (breeze 2): development and Evaluation study. JMIR Serious Games. 2022;10(3):e39186. doi:10.2196/39186.
   PubMed Web of Science ®Google Scholar
• Michaelsen MM, Esch T. Motivation and reward mechanisms in health behavior change processes. Brain Res. 2021;1757:147309. doi:10.1016/j.brainres.2021.147309.
   PubMed Web of Science ®Google Scholar
• Vlaev I, King D, Darzi A, Dolan P. Changing health behaviors using financial incentives: a review from behavioral economics. BMC Public Health. 2019;19(1):1059. doi:10.1186/s12889-019-7407-8.
   PubMed Web of Science ®Google Scholar
• Castro O, Mair JL, Salamanca-Sanabria A, Alattas A, Keller R, Zheng S, Jabir, A, Lin, X, Frese, BF, Lim, CS, et al. Development of “LvL UP 1.0”: a smartphone-based, conversational agent-delivered holistic lifestyle intervention for the prevention of non-communicable diseases and common mental disorders. Frontiers Digital Health. 2023;5:1039171. doi:10.3389/fdgth.2023.1039171.
   PubMedGoogle Scholar
• Ollier J, Neff S, Dworschak C, Sejdiji A, Santhanam P, Keller R, Xiao G, Asisof A, Rüegger D, Bérubé C, et al. Elena+ care for COVID-19, a pandemic lifestyle care intervention: intervention design and study protocol. Front Public Health. 2021;9:625640. doi:10.3389/fpubh.2021.625640.
   PubMed Web of Science ®Google Scholar
• Karavasiloglou N, Pestoni G, Wanner M, Faeh D, Rohrmann S, Cheng X. Healthy lifestyle is inversely associated with mortality in cancer survivors: results from the Third national health and nutrition examination survey (NHANES III). PloS One. 2019;14(6):e0218048. doi:10.1371/journal.pone.0218048.
   PubMed Web of Science ®Google Scholar
• GBDCRF C. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400:563–591.
   PubMed Web of Science ®Google Scholar
• Guglielmi G. Almost half of cancer deaths are preventable. Nature. 2022. doi:10.1038/d41586-022-02355-x.
   Google Scholar
• Gallant MP. 305Social networks, social support, and health-related behavior. In: Martin L, and DiMatteo M editors. The Oxford Handbook of Health Communication, behavior change, and treatment adherence. Oxford University Press; 2013. p. 0. https://academic.oup.com/edited-volume/28130/chapter-abstract/212327762?redirectedFrom=fulltext.
   Google Scholar
• Arnason A, Langarica N, Dugas LR, Mora N, Luke A, Markossian T. Family-based lifestyle interventions: what makes them successful? A systematic literature review. Prev Med Rep. 2021;21:101299.
   PubMedGoogle Scholar
• Greaney ML, Puleo E, Sprunck-Harrild K, Haines J, Houghton SC, Emmons KM. Social support for changing multiple behaviors: factors associated with seeking support and the impact of Offered support. Health Education & Behavior. 2018;45(2):198–206. doi:10.1177/1090198117712333.
   PubMed Web of Science ®Google Scholar
• Mair JL, Salamanca-Sanabria A, Augsburger M, Frese BF, Abend S, Jakob R, Kowatsch T, Haug S. Effective behavior change techniques in Digital health interventions for the prevention or management of noncommunicable diseases: an umbrella review. Ann Behav Med. 2023;57(10): 817–835. doi:10.1093/abm/kaad041.
   PubMedGoogle Scholar
• Wang ML, Lemon SC, Clausen K, Whyte J, Rosal MC. Design and methods for a community-based intervention to reduce sugar-sweetened beverage consumption among youth: H(2)GO! study. BMC Public Health. 2016;16:1150.
   PubMed Web of Science ®Google Scholar
• Keller R, Hartmann S, Teepe GW, Lohse KM, Alattas A, Tudor Car L, Müller-Riemenschneider F, von Wangenheim F, Mair JL, Kowatsch T, et al. Digital behavior change interventions for the prevention and management of type 2 diabetes: systematic market analysis. J Med Internet Res. 2022;24(1):e33348. doi:10.2196/33348.
   PubMed Web of Science ®Google Scholar
• Safavi K, Mathews SC, Bates DW, Dorsey ER, Cohen AB. Top-Funded Digital health companies and their impact on high-burden, high-cost conditions. Health Aff (Millwood). 2019;38:115–123.
   PubMed Web of Science ®Google Scholar
• Keum J, Chung MJ, Kim Y, Ko H, Sung MJ, Jo JH, Park JY, Bang S, Park SW, Song SY, et al. Usefulness of smartphone apps for improving nutritional status of pancreatic cancer patients: randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(8):e21088. doi:10.2196/21088.
   PubMed Web of Science ®Google Scholar
• Low CA, Danko M, Durica KC, Vega J, Li M, Kunta AR, Mulukutla R, Ren Y, Sereika SM, Bartlett DL, et al. A real-time Mobile intervention to reduce sedentary behavior before and after cancer surgery: Pilot randomized controlled trial. JMIR Perioper Med. 2023;6:e41425. doi:10.2196/41425.
   PubMedGoogle Scholar
• Phillips SM, Penedo FJ, Collins LM, Solk P, Siddique J, Song J, Cella D, Courneya KS, Ackermann RT, Welch WA, et al. Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: results from Fit2Thrive. Cancer. 2022;128(5):1122–1132. doi:10.1002/cncr.34012.
   PubMed Web of Science ®Google Scholar
• Blair CK, Harding E, Wiggins C, Kang H, Schwartz M, Tarnower A, Du R, Kinney AY. A home-based Mobile health intervention to Replace sedentary time with light physical activity in older cancer survivors: randomized controlled Pilot trial. JMIR Cancer. 2021;7(2):e18819.
   PubMed Web of Science ®Google Scholar
• Subnis UB, Farb NA, Piedalue KL, Speca M, Lupichuk S, Tang PA, Faris P, Thoburn M, Saab BJ, Carlson LE. A smartphone app-based mindfulness intervention for cancer survivors: protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(5):e15178.
   PubMed Web of Science ®Google Scholar
• Borosund E, Ehlers SL, Clark MM, Andrykowski MA, Cvancarova Smastuen M, Solberg Nes L. Digital stress management in cancer: testing StressProffen in a 12-month randomized controlled trial. Cancer. 2022;128(7):1503–1512. doi:10.1002/cncr.34046.
   PubMed Web of Science ®Google Scholar
• Stern AD, Bronneke J, Debatin JF, Hagen J, Matthies H, Patel S, Clay I, Eskofier B, Herr A, Hoeller K, et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit Health. 2022;4(3):e200–e6.
   PubMedGoogle Scholar
• Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JS. Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature. J Multidiscip Healthc. 2018;11:49–61. doi:10.2147/JMDH.S117945.
   PubMed Web of Science ®Google Scholar
• Prabhu Das I, Baker M, Altice C, Castro KM, Brandys B, Mitchell SA. Outcomes of multidisciplinary treatment planning in US cancer care settings. Cancer. 2018;124(18):3656–3667. doi:10.1002/cncr.31394.
   PubMed Web of Science ®Google Scholar
• JC H. Psycho-oncology: overview, obstacles and opportunities. Psychooncology. 2018;27:1364–1376.
   PubMed Web of Science ®Google Scholar